Open AccessExploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy
Author(s) -
Anshika Chauhan,
Rajandeep Kaur,
Sushmita Ghoshal,
Arnab Pal
Publication year - 2020
Publication title -
indian journal of clinical biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.392
H-Index - 42
ISSN - 0970-1915
DOI - 10.1007/s12291-020-00923-4
Subject(s) - circulating tumor cell , liquid biopsy , micrometastasis , biopsy , cancer , medicine , computational biology , pathology , oncology , metastasis , biology
Circulating tumour cells (CTCs), are disseminated tumour cells found in the blood in solid tumour malignancies. Identification of CTCs act as emerging tools in the field of the Liquid Biopsy. Majority of the studies focused on detection and enumeration of CTCs due to technological challenges those results from the rarity of CTCs in the blood. Enumeration of CTCs has already proven their value as prognostic as well as predictive biomarkers for disease prognosis. However, recent advances in technology permitted to study the molecular and functional features of CTCs and these features have the potential to change the diagnostic, prognostic and predictive landscape in oncology. In this review, we summarize the paradigm shift in the field of liquid biopsy-based cancer diagnostics using CTC isolation and detection. We have discussed recent advances in the technologies for molecular characterization of CTCs which have aided a shift from CTC enumeration to an in-depth analysis of the CTC genome, transcriptomes, proteins, epigenomes along with various functional features. Finally, as a prognosticating strategy, the potentials of CTCs as a tool of liquid biopsy to predict micrometastasis, monitor prognosis and how to use them as an additional tool for cancer staging has been discussed.